The End-to-End AI Pipeline

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most transformative shifts in modern drug discovery: the emergence of end-to-end AI-driven pharmaceutical pipelines. Moving beyond isolated applications of artificial intelligence, this episode focuses on how companies like Insilico Medicine are integrating AI across the entire value chain—from target identification to clinical trial design.

Dr. Jagota provides a detailed analysis of Insilico’s Pharma.AI platform, which combines three interconnected engines: PandaOmics for target discovery, Chemistry42 for generative molecular design, and InClinico for predicting clinical trial success. This unified architecture represents a fundamental departure from traditional, fragmented R&D processes, enabling a continuous, data-driven approach to therapeutic development.

The episode highlights a landmark case study: INS018_055 (rentosertib), one of the first drugs fully discovered and designed using AI to reach human clinical trials. Dr. Jagota examines the unprecedented speed and efficiency of its development—achieved in a fraction of the time and cost of conventional methods—as well as its Phase 2a clinical validation, marking a critical proof-of-concept for AI-native drug discovery.

By connecting technological innovation with real-world clinical outcomes, this episode demonstrates how AI is transforming drug development into a predictive, scalable, and economically viable system, redefining both scientific workflows and industry expectations.

For deeper insights, strategic perspectives, and Dr. Jagota’s ongoing work in AI-driven healthcare innovation, please visit: 🌐 https://nirdoshjagota.us/

🌐 https://nirdoshjagota.net/

🌐 https://nirdoshjagota.com/

🌐 https://aboutnirdoshjagota.com/

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(16)

2040: A Day in the Life

What could an ordinary day in medicine look like in the year 2040? In the season finale of The Quantum Leap, Dr. Nirdosh Jagota imagines a single day in a future shaped by artificial intelligence, gen...

16 Sep 15min

The Great Integration

How Big Pharma Is Adopting, Acquiring, and Competing with Deep Tech What does a century-old pharmaceutical company do when the future arrives from a technology company? In this episode of The Quantum ...

16 Sep 14min

The Sentient Supply Chain

In this episode of The Quantum Leap, Dr. Nirdosh Jagota steps onto the pharmaceutical factory floor to examine how artificial intelligence, advanced optimization, continuous manufacturing, and digital...

17 Aug 13min

The Black Box Dilemma

In this episode of The Quantum Leap, Dr. Nirdosh Jagota examines one of the most important challenges facing AI and quantum medicine: how clinicians, regulators, and patients can trust decisions produ...

17 Aug 12min

The Quantum Doctor

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores how quantum computing could move beyond pharmaceutical research and into hospitals, diagnostics, genomics, and personalized patient car...

24 Juli 8min

Solving the Unsolvable

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: quantum simulation. Building on the foundation of quantum computing in...

24 Juli 9min

The Quantum Dawn

In this milestone episode of The Quantum Leap, Dr. Nirdosh Jagota introduces one of the most transformative technologies on the horizon: quantum computing. As artificial intelligence continues to resh...

15 Juni 8min

The New AI Scientist

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most profound shifts in the history of scientific discovery: the emergence of AI as an active research partner. Moving beyon...

15 Juni 9min